Educational Event for Surgeons To Be Held at the Intrepid Sea Air & Space
Museum in New York
WAYNE, N.J., Nov. 3 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading
provider of cardiovascular technologies, announced today that it will
celebrate the golden anniversary of its vascular grafts line with an
educational event featuring Michael L. Marin, M.D., Professor and Chairman of
Surgery at Mt. Sinai Hospital in New York.
Dr. Marin will give a clinical presentation during a dinner for surgeons to be
held on November 19 from 6:30-10:30 p.m. EST at the Intrepid Sea Air & Space
Museum on the Intrepid aircraft carrier at Pier 96 in New York. Dr. Marin's
presentation, entitled, "A History of Aortic Surgery," will cover the history
of vascular grafts and endovascular devices and how their introduction has
fueled advancements in aortic surgery.
"The HEMASHIELD graft legacy dates back to innovation that began in the 1950s
with a group of visionary surgeons and continues today," said Raoul Quintero,
President and CEO, MAQUET Cardiovascular U.S. Sales LLC. "From a single
vascular graft introduced decades ago, the HEMASHIELD line has grown to
include an incomparable array of vascular grafts designed to help surgeons
treat patients with narrowed, blocked or dilated arteries. MAQUET is committed
to continuing to provide vascular surgeons with innovative and convenient
clinical solutions to improve the outcomes of patients with vascular disease,
a leading cause of morbidity and mortality worldwide."
HEMASHIELD grafts, used for surgical repair of aneurysmal and occluded
arteries, are the most studied and used vascular products available on the
market today. HEMASHIELD grafts have demonstrated clinical efficacy and
improved patient outcomes. Published data have shown that they promote natural
healing and long-term patency, and that patients benefit from reduced
procedure time. More than 2 million HEMASHIELD grafts have been implanted in
patients worldwide.
"This Golden Anniversary event celebrates the pioneering surgeons who have
pushed the boundaries over the last five decades to deliver new and better
life-saving interventions to their patients. This event also affirms MAQUET's
dedication to surgeon education and our partnership with physicians in
developing revolutionary vascular graft technology," said William Friedberg,
President, MAQUET Cardiovascular's Vascular Interventions business unit. "As
we enter the sixth decade of vascular grafts, we will continue to build on our
50-year history of innovation and our partnership with our customers as we
launch a new family of vascular grafts for peripheral vascular procedures."
About The MAQUET Group
The MAQUET Group is the global market leader for Medical Systems, focusing on
the Operating Room (OR) and Intensive Care Unit (ICU). The integrated products
of MAQUET are specially designed to deliver optimal clinical treatment and
therapy concepts within acute care hospitals. MAQUET provides innovative
medical solutions from three Divisions:
-- Cardiovascular -- with products for cardiac assist (intra-aortic
balloon
counterpulsation therapy), coronary artery bypass surgery, heart valve
repair, aneurysm and vascular repair, peripheral interventions and
extracorporeal circulation
-- Critical Care -- for intensive care ventilators and anesthesia
machines
-- Surgical Workplaces -- for OR tables, lights and ceiling service
units,
prefabricated OR and ICU suites as well as telemedicine for the OR
integration.
MAQUET is a subsidiary of the publicly-listed Swedish GETINGE GROUP, a company
with over $2.8 billion in revenues (2008 fiscal year) and 12,800 employees
worldwide. In 2008 MAQUET itself generated pro-forma revenues (including the
acquisition of Datascope Corp.) of over $1.4 billion. The company now has
5,000 employees in 34 international sales and service organizations, as well
as a network of more than 200 sales representatives.
www.maquet.com
www.getingegroup.com
MAQUET - The Gold Standard.
SOURCE MAQUET Cardiovascular LLC
Philip Freed of MAQUET Cardiovascular LLC, +1-973-709-7514, Mobile,
+1-917-806-8464, philip.freed@maquet.com
